Storia in 2 fonti

Two Deaths In China Reopen Gene Therapy Debates

Two undisclosed deaths in Chinese gene-editing trials renew concerns about trial oversight, safety reporting, and transparency as gene therapy advances worldwide.

Raccontata da

timesofindia.indiatimes.com

forbes.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

forbes.comStai leggendo3 g fa

Two Deaths In China Reopen Gene Therapy Debates

Two undisclosed deaths in Chinese gene-editing trials renew concerns about trial oversight, safety reporting, and transparency as gene therapy advances worldwide.

originale

timesofindia.indiatimes.com6 g fa

Patient dies in China biotech company’s gene editing trial

A patient with Duchenne muscular dystrophy died after receiving a gene-editing therapy in China, sparking new concerns about regulatory oversight and transparency as China seeks to cement its position as a biotechnology…

Leggi questa versione → originale

Timeline cronologica

venerdì 7 agosto 2026·timesofindia.indiatimes.com
Patient dies in China biotech company’s gene editing trial
A patient with Duchenne muscular dystrophy died after receiving a gene-editing therapy in China, sparking new concerns about regulatory oversight and transparency as China seeks…
lunedì 10 agosto 2026·forbes.com
Two Deaths In China Reopen Gene Therapy Debates
Two undisclosed deaths in Chinese gene-editing trials renew concerns about trial oversight, safety reporting, and transparency as gene therapy advances worldwide.